Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial

Data-Driven Definitions for Active and Structural MRI Lesions in the Sacroiliac Joint in Spondyloarthritis and their Predictive Utility

(2021) Walter P Maksymowych et al.   RHEUMATOLOGY

How should we define disease and outcomes in axial psoriatic arthritis?

(2021) Laura C Coates   Lancet Rheumatology

Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies

(2021) Philip J Mease et al.   Lancet Rheumatology

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

(2020) Philip J Mease et al.   LANCET

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

(2020) Atul Deodhar et al.   LANCET

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

(2020) Xenofon Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results

(2019) Philip Mease   Arthritis & Rheumatology

Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?

(2019) Joy Feld et al.   RHEUMATOLOGY

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

(2018) Pedro M Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

(2018) Philip J. Mease et al.   JOURNAL OF RHEUMATOLOGY

Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain

(2018) Janneke de Winter et al.   Arthritis & Rheumatology

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

(2018) Dominique Baeten et al.   ANNALS OF THE RHEUMATIC DISEASES

Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

(2018) Atul Deodhar et al.   Arthritis & Rheumatology

Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?

(2018) Stefan Siebert et al.   ANNALS OF THE RHEUMATIC DISEASES

What Is Axial Psoriatic Arthritis?

(2018) JOY FELD et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)

(2016) Arthur Kavanaugh et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases

(2016) Agnieszka Wasilewska et al.   Postepy Dermatologii i Alergologii

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

(2015) Monika M Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the Hand and Foot in a Randomized Placebo-controlled Trial

(2015) D. Glinatsi et al.   JOURNAL OF RHEUMATOLOGY

Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy

(2014) D. R. Jadon et al.   JOURNAL OF RHEUMATOLOGY

The 5-point Investigator’s Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials

(2013) Richard G. B. Langley et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

(2013) A.-W. Chan et al.   BMJ-British Medical Journal

Sensitivity and specificity of the Classification of Psoriatic Arthritis criteria in early psoriatic arthritis

(2012) Laura C. Coates et al.   ARTHRITIS AND RHEUMATISM

Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study

(2012) Laura Niccoli et al.   International Journal of Rheumatic Diseases

Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis

(2011) Lihi Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis

(2011) Q. Yang et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

(2010) P. Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?

(2010) L. Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS): Definitions of Key Pathologies, Suggested MRI Sequences, and Preliminary Scoring System for PsA Hands

(2009) M. OSTERGAARD et al.   JOURNAL OF RHEUMATOLOGY

Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway

(2009) J. C. Nossent et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

(2008) C Lukas et al.   ANNALS OF THE RHEUMATIC DISEASES